KLK3 and posterior cortical atrophy: The measurement of these PCa-specific genes in combination with traditional clinical risk factors—such as age, serum PSA level, prostate volume, family history of PCa, and the outcome of a DRE result—compose a patient’s SelectMDx personalized risk score.